109 filings
Page 4 of 6
8-K
ie8zv t74knbc
20 Feb 20
Termination of a Material Definitive Agreement
6:01am
8-K
i935yw
10 Jan 20
Matinas BioPharma Announces Proposed Public Offering of Common Stock
4:50pm
8-K
6j7lueyt9e5
1 Nov 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
dpxz8z
13 Aug 19
Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
7:00am
8-K
6uwz5xxfgdh xzll5
14 May 19
Matinas BioPharma Provides Corporate Update and Reports First Quarter 2019 Financial Results
7:05am
8-K
jb781uysth5
2 Apr 19
Matinas BioPharma Reports 2018 Financial Results and Provides Corporate Update
7:20am
8-K
3ugtobew sk
15 Mar 19
Matinas BioPharma Announces Proposed Public Offering of Common Stock
5:15pm
8-K
p364 mviui4mxs
25 Feb 19
Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer
8:15am
8-K
7w6lnd
3 Jan 19
Matinas BioPharma Appoints Keith A. Kucinski, CPA, MBA as Chief Financial Officer
8:05am
8-K
dbw 22w62
2 Nov 18
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
0bzg3bwu
15 Oct 18
Departure of Directors or Certain Officers
8:00am
8-K
0zp8pmducbbinx89o
6 Sep 18
Matinas BioPharma Announces Appointment of Industry Leader Patrick G. LePore to Board of Directors
12:00am
8-K
qp8gzxe
19 Jun 18
Matinas BioPharma Announces Pricing of $8.0 Million Public Offering
5:19pm
8-K
03qzy 6jul5q1xdcn6a9
18 Jun 18
Departure of Directors or Certain Officers
5:23pm
8-K
kmbyrb
25 May 18
Other Events
11:17am
8-K
e0oruleu1 cq65t3
27 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
9l8z0vg r2t
8 Jan 18
Other Events
12:00am
8-K
zb1 r21vn0e97cf0
14 Dec 17
Matinas BioPharma Appoints Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A., to Board of Directors
12:00am
8-K
5lsu4yrj
26 Oct 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
o78ukqo
10 Aug 17
Regulation FD Disclosure
12:00am